Lilly's weekly fluoxetine captures .8% of new antidepressant scripts, with sales of $6 mil. in the second quarter. The dollar number does not reflect actual Prozac Weekly total prescriptions due to Lilly's 30-day coupon program during the quarter, Investor Relations Director Simon Harford explains. Prozac/Sarafem sales were up 10% to $692.4 mil. Part of the growth is attributable to a 4% price increase on May 1. A 20 mg capsule now costs $2.96 per day of therapy
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth